Topic: How To Invest

Spinoffs & Takeovers Hotline – Friday, January 29, 2021

Article Excerpt

COLFAX CORP., $37.12, symbol CFX on New York, operates in two main segments: Through its Medical Technologies unit (35% of sales), it’s a leading provider of orthopedic technologies and medical devices. Through its Fabrication Technology segment (65% of sales), it manufactures consumable products and equipment for the cutting, joining, and automated welding of metals. On January 19, 2021, Colfax announced that its Medical Technologies business had acquired Trilliant Surgical. That company provides foot and ankle orthopedic implants. The purchase price has not yet been disclosed. The Trilliant acquisition strengthens Colfax’s position in the expanding foot and ankle market in the U.S. Trilliant offers more than 15 product lines, of which many products are patented. It is well recognized for providing its novel Arsenal Foot Plating System. Trilliant also complements the STAR system that Colfax acquired in November 2020. The Scandinavian Total Ankle Replacement (STAR) system holds a leading position in the global ankle arthroplasty market. Arthroplasty is a surgical procedure to restore the…